Herbalife Reports Q3 2026 Financial Results
Herbalife Ltd. reported Q3 2026 net sales of $1.35B, up 6% YoY, with regional growth varying. Adjusted EBITDA was $182.4M, EPS $0.55. Gross margin slightly declined to 77.3%. The company cited refinancing benefits and debt reduction. Management expects continued net sales growth.
How this was made
The 30-second read
Why it matters
The combination of guidance outperformance, adjusted EBITDA margin expansion, and reduced net interest expense from an April refinancing is likely to drive near-term earnings estimate revisions and sentiment, while the gross margin decline and leverage level may temper enthusiasm.
Market read
Company-specific earnings print with multiple decision-relevant metrics (sales growth, EPS, EBITDA, margins, refinancing impact, leverage) that can move positioning and estimates.
What to watch
Net leverage is still 2.0x with total debt of $2.0B; investors may focus on whether continued debt reduction and repurchases are sustainable if margin pressure returns.
Background
The article is a first-report style earnings release for Herbalife’s Q3 2026 results, including regional sales growth, profitability metrics, and capital structure commentary.
Ticker impact
Herbalife reported Q3 2026 net sales of $1.35B, adjusted EBITDA of $182.4M, and EPS of $0.55, citing guidance outperformance and margin expansion.
Likely upward bias as the market prices in beat-and-margin expansion and improved interest expense, though investors may still scrutinize gross margin pressure and leverage.
The article provides multiple company-specific datapoints (sales growth, EBITDA, EPS, margin change, refinancing impact, leverage) that typically drive earnings revisions and sentiment. However, it lacks explicit forward guidance numbers beyond expecting net sales growth for the remainder of the year.
Market effects
Adds datapoints on demand and profitability trends for direct-selling/consumer wellness peers, especially around regional growth and margin sensitivity to sourcing mix.
Highlights North America stabilization and stronger Asia Pacific growth, which can influence regional sentiment for similar consumer brands.
Limited broader macro relevance, but refinancing-driven interest expense reduction can matter for leveraged consumer names’ earnings quality.
Counterpoint
Gross profit margin fell to 77.3% from 77.7% due to sales mix pressure and self-manufacturing/sourcing costs, which could signal underlying margin headwinds despite the EBITDA beat.
Key entities
- companyHerbalife Ltd.
Reported Q3 2026 net sales, adjusted EBITDA, diluted EPS, margin changes, and capital structure metrics, citing guidance outperformance and refinancing benefits.
- executiveScott Schaefer
CFO quoted on guidance beat, EBITDA margin expansion, and refinancing impact on net interest expense.
- executiveJohn DeSimone
Interim CEO quoted on continued net sales growth expectations and business priorities.
